Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer-Reference-Cited by-同舟云学术

Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer

Published:2020-01 Issue:1 Volume:20 Page:125-131
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Hank Thomas,Sandini Marta^ORCID,Qadan Motaz^ORCID,Weniger Maximilian^ORCID,Ciprani Debora,Li Annie,Ferrone Cristina R.,Warshaw Andrew L.,Lillemoe Keith D.,Fernández-del Castillo Carlos

Funder

German Cancer Aid

German Research Foundation

Boehringer Ingelheim Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference54 articles.

1. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

2. Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis;Janssen;J Natl Cancer Inst,2019

3. Optimizing the outcomes of pancreatic cancer surgery;Strobel;Nat Rev Clin Oncol,2019